|
|
|
Figure 1
Clinically used HDAC inhibitors based on a hydroxamate zinc-binding group. The commercial names are indicated in parentheses. |
Open
access
access|
|
|
Figure 1
Clinically used HDAC inhibitors based on a hydroxamate zinc-binding group. The commercial names are indicated in parentheses. |
access